Fluorometric screening for metabolism-based drug-drug interactions

Journal of Pharmacological and Toxicological Methods

Volumn 44, Issue 1, 2000, Pages 325-331

  Crespi, Charles L ^a   Stresser, David M ^a  

^a Gentest Corporation   (United States)

Author keywords

ADME; Cytochrome P 450; Drug interactions; High throughput screening

Indexed keywords

CISAPRIDE; CYTOCHROME P450; DRUG METABOLIZING ENZYME; LANSOPRAZOLE; QUINIDINE;

ARTICLE; DRUG METABOLISM; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; METHODOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INHIBITORS; FLUOROMETRY; HUMANS; MIXED FUNCTION OXYGENASES; OMEPRAZOLE;

EID: 0034460075     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00112-X     Document Type: Article

References (26)

1. Guidance for industry. Drug metabolism/drug interaction studies in the drug development process: Studies in vitro
2. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450
3. Effect of common solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes
4. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450
5. High throughput screening for inhibition of cytochrome P450 metabolism
6. Improved reliability of the rapid microtiter plate assay using recombinant enzyme in predicting CYP2D6 inhibition in human liver microsomes
7. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
8. Characterization of the common genetic defect in human deficient for debrisoquine metabolism
9. Role of cytochrome P450 enzymes in drug-drug interactions
10. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities
11. CYP3A4 drug interactions: Correlation of 10 in vitro probes substrates
12. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to the cytochrome P450 active sites
13. The substrate binding site of human liver cytochrome P450 2C9: An approach using designed tienilic acid derivatives and molecular modeling
14. Life-threatening interactions of mibefradil and beta-blockers with dihydropyridine calcium channel blockers
15. P450 enzymes. Inhibition mechanism, genetic regulation and effects of liver disease
16. Nonspecific binding to microsomes: Impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine and propranalol
17. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers and inhibitors
18. (O-methyl C-14)naproxen O-demethylase activity in human liver microsomes-evidence for the involvement of cytochrome P4501A2 and P4502C9/10
19. 14C]-dextromethorphan
20. 14C]Phenacetin O-deethylase activity in human liver microsomes
21. Clinical importance of hepatic cytochrome P450 in drug metabolism
22. Co-operativity in oxidation catalyzed by cytochrome P450 3A4
23. Human cytochrome P-450 3A4: In vitro drug-drug interaction patterns are substrate-dependent
24. Human cytochrome P4503A4-catalyzed testosterone 6(beta)-hydroxylation and erythromycin N-demethylation: Competition during catalysis
25. Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylase
26. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen